Example: Heart Attack

Search clinical trials for: Flutamide

Total 68 results

NCT04248621

Recruiting

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Conditions: Prostatic Neoplasms
NCT03678025

Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Conditions: Castration Levels of Testosterone; Metastatic Prostatic Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8
NCT03507608

Recruiting

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Conditions: Prostate Cancer
NCT03488810

Not yet recruiting

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Conditions: Prostate Cancer
NCT03070886

Recruiting

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Conditions: Stage I Prostate Adenocarcinoma; Stage II Prostate Adenocarcinoma; Stage III Prostate Adenocarcinoma
NCT02918968

Completed

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

Conditions: Prostate Cancer
NCT02911350

Completed

Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer

Conditions: Prostate Cancer
NCT02799706

Recruiting

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT02742675

Active, not recruiting

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Conditions: Prostate Cancer
NCT02454543

Active, not recruiting

Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases

Conditions: Prostate Cancer
NCT02376296

Unknown status

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Conditions: Prostate Cancer
NCT02346578

Completed

Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

Conditions: Castration-resistant Prostate Cancer
NCT02341404

Completed

A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer

Conditions: Prostate Cancer
NCT01889199

Recruiting

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Conditions: Polycystic Ovary Syndrome (PCOS)
NCT01786265

Active, not recruiting

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Participants With Recurrent Prostate Cancer

Conditions: Prostate Adenocarcinoma; Recurrent Prostate Carcinoma
NCT01546987

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Conditions: Prostate Cancer
NCT01428193

Terminated

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
NCT01122121

Completed

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

Conditions: Prostatic Neoplasms, Locally Advanced
NCT01011751

Completed

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Conditions: Adenocarcinoma, Prostate
NCT00936390

Active, not recruiting

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00930228

Recruiting

Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT00913263

Completed

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

Conditions: Prostate Cancer
NCT00850941

Active, not recruiting

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Conditions: Prostate Cancer
NCT00817739

Completed

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Conditions: Prostatic Neoplasms
NCT00769548

Completed

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00767286

Completed

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00729560

Terminated

Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT00699907

Completed

Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

Conditions: Ovarian Cancer
NCT00651326

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

Conditions: Prostate Cancer
NCT00611923

Completed

Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder

Conditions: Premenstrual Syndrome
NCT00567580

Active, not recruiting

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Conditions: Prostate Cancer
NCT00528866

Completed

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Conditions: Prostate Cancer
NCT00512668

Terminated

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
NCT00450463

Completed

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

Conditions: Prostate Cancer
NCT00442689

Completed

Metabolic Syndrome in PCOS: Precursors and Interventions

Conditions: Polycystic Ovary Syndrome; Metabolic Syndrome
NCT00388804

Terminated

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Conditions: Prostate Cancer
NCT00309985

Active, not recruiting

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

Conditions: Metastatic Hormone-sensitive Prostate Cancer
NCT00303784

Recruiting

Prostate Adenocarcinoma TransCutaneous Hormones

Conditions: Anemia; Cardiovascular Complications; Hot Flashes; Osteoporosis; Prostate Cancer
NCT00283803

Completed

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Conditions: Prostate Cancer
NCT00223665

Completed

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Conditions: Prostate Cancer
NCT00170157

Completed

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Conditions: Prostate Adenocarcinoma; Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage III Prostate Cancer; Stage IV Prostate Cancer
NCT00175396

Unknown status

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Conditions: Prostate Cancer
NCT00116220

Active, not recruiting

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Conditions: Prostate Cancer
NCT00104741

Unknown status

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Conditions: Prostate Cancer
NCT00002881

Completed

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00006214

Completed

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Conditions: Prostate Cancer
NCT00002889

Completed

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00002597

Completed

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Conditions: Prostate Cancer
NCT00026377

Completed

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00003734

Unknown status

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer

Search clinical trials for: Flutamide

Recent CRA jobs

CRA (Level II)

Research Scientist

Commercial Analyst - Cambridge

(Senior) Optimization Specialist - PVG, EMEA or APAC

Prin Optimization Specialist - PVG, EMEA or APAC

Compliance Specialist - Home Based

Associate Data Manager - Labs

CRA - Client-dedicated, Vaccines - Finland

Associate Director/Director, Site Intelligence and Activation (oversight)

Statistical Analyst